Search

Your search keyword '"D'Amato, Daphne"' showing total 110 results

Search Constraints

Start Over You searched for: Author "D'Amato, Daphne" Remove constraint Author: "D'Amato, Daphne"
Sorry, I don't understand your search. ×
110 results on '"D'Amato, Daphne"'

Search Results

1. Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis

Catalog

Books, media, physical & digital resources

3. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

4. THU-161 Hepatic sarcoidosis diagnosis and management: an italian multicenter study

5. LBP-038 Expanding knowledge regarding real-world treatment of patients with primary biliary cholangitis with obeticholic acid from the Italian RECAPITULATE cohort

6. THU-133-YI Radiomics for prognostication in primary sclerosing cholangitis: a proof-of-concept using GLRLM run entropy

7. THU-093 Biochemical response and liver stiffness variation over time predict liver-related events in patients with primary biliary cholangitis treated with Obeticholic acid

8. Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.

9. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

10. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

11. Real-world experience with obeticholic acid in patients with primary biliary cholangitis

12. Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison

14. Prognostic value of simple non-invasive tests for the risk stratification of HCC development in patients with cirrhosis due to non-alcoholic fatty liver disease

15. Glucose and lipid metabolism alterations after an oral lipid meal in patients with non-alcoholic fatty liver disease carrying the PNPLA3 rs738409 polymorphism

16. Impact of PNPLA3 rs738409 single nucleotide polymorphism and carbohydrate intake for the personalized management of patients with non-alcoholic fatty liver disease

17. Interferon gamma-induced protein 10 levels increase across the spectrum of liver disease and are associated with insuline resistant components in subjects with non-alcoholic fatty liver disease

18. Influence of chronotype and adherence to the mediterranean diet on the risk of liver fibrosis in patients with non-alcoholic fatty liver disease

19. Echocardiography-based markers for subclinical cardiac dysfunction in patients with non-alcoholic fatty liver disease and significant fibrosis with preserved ejection fraction: preliminary data from a prospective monocentric Italian cohort

20. Long-term real-world experience with obeticholic acid in primary biliary cholangitis: the Italian recapitulate study

21. Development and validation of a score predicting response to obeticholic acid in primary biliary cholangitis: the OCA response score (ORS)

22. AGILE 3+ and AGILE 4 scores for the diagnosis of advanced fibrosis and cirrhosis in patients with non-alcoholic fatty liver disease

23. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

24. Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease

25. Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

26. Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis

27. Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis

29. Radiomics-based model for outcome prediction in primary sclerosing cholangitis

30. Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581]

31. EP1211: RADIOMICS-BASED MODEL FOR OUTCOME PREDICTION IN PRIMARY SCLEROSING CHOLANGITIS

33. Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease

34. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

35. Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid.

36. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

37. Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison

38. Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach

39. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

40. SAT-494 - Echocardiography-based markers for subclinical cardiac dysfunction in patients with non-alcoholic fatty liver disease and significant fibrosis with preserved ejection fraction: preliminary data from a prospective monocentric Italian cohort

42. THU-470 - Impact of PNPLA3 rs738409 single nucleotide polymorphism and carbohydrate intake for the personalized management of patients with non-alcoholic fatty liver disease

43. THU-452 - Interferon gamma-induced protein 10 levels increase across the spectrum of liver disease and are associated with insuline resistant components in subjects with non-alcoholic fatty liver disease

44. THU-435 - Influence of chronotype and adherence to the mediterranean diet on the risk of liver fibrosis in patients with non-alcoholic fatty liver disease

45. THU-415 - Glucose and lipid metabolism alterations after an oral lipid meal in patients with non-alcoholic fatty liver disease carrying the PNPLA3 rs738409 polymorphism

47. OS-070 - Development and validation of a score predicting response to obeticholic acid in primary biliary cholangitis: the OCA response score (ORS)

48. OS-045 - Long-term real-world experience with obeticholic acid in primary biliary cholangitis: the Italian recapitulate study

49. Accuracy of liver stiffness measurement in assessing liver fibrosis in naive patients with primary biliary cholangitis

50. New Therapeutic Targets in Autoimmune Cholangiopathies